Amneal Pharmaceuticals, Class Stock Alpha and Beta Analysis
| AMRX Stock | USD 8.39 0.07 0.84% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Amneal Pharmaceuticals, Class. It also helps investors analyze the systematic and unsystematic risks associated with investing in Amneal Pharmaceuticals, over a specified time horizon. Remember, high Amneal Pharmaceuticals,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Amneal Pharmaceuticals,'s market risk premium analysis include:
Beta 0.95 | Alpha (0.05) | Risk 1.77 | Sharpe Ratio (0.0007) | Expected Return (0) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Amneal |
Amneal Pharmaceuticals, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Amneal Pharmaceuticals, market risk premium is the additional return an investor will receive from holding Amneal Pharmaceuticals, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Amneal Pharmaceuticals,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Amneal Pharmaceuticals,'s performance over market.| α | -0.05 | β | 0.95 |
Amneal Pharmaceuticals, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Amneal Pharmaceuticals,'s Buy-and-hold return. Our buy-and-hold chart shows how Amneal Pharmaceuticals, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Amneal Pharmaceuticals, Market Price Analysis
Market price analysis indicators help investors to evaluate how Amneal Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amneal Pharmaceuticals, shares will generate the highest return on investment. By understating and applying Amneal Pharmaceuticals, stock market price indicators, traders can identify Amneal Pharmaceuticals, position entry and exit signals to maximize returns.
Amneal Pharmaceuticals, Return and Market Media
The median price of Amneal Pharmaceuticals, for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 8.49 with a coefficient of variation of 2.5. The daily time series for the period is distributed with a sample standard deviation of 0.21, arithmetic mean of 8.54, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 76453 shares by Jeffrey George of Amneal Pharmaceuticals, subject to Rule 16b-3 | 08/30/2024 |
2 | Earnings Preview Amneal Pharmaceuticals Q3 Earnings Expected to Decline | 11/01/2024 |
3 | Amneal Q3 Earnings on the Horizon Analysts Insights on Key Performance Measures | 11/06/2024 |
4 | Earnings To Watch Amneal Pharmaceuticals Inc Reports Q3 2024 Result | 11/07/2024 |
5 | Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts | 11/08/2024 |
6 | Amneal Pharmaceuticals, Inc. Sees Significant Drop in Short Interest | 11/15/2024 |
7 | Senior VP Of Amneal Pharmaceuticals Sold 76 percent Of Their Shares | 11/21/2024 |
About Amneal Pharmaceuticals, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Amneal or other stocks. Alpha measures the amount that position in Amneal Pharmaceuticals, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.0957 | 0.096 | Price To Sales Ratio | 0.45 | 0.42 |
Amneal Pharmaceuticals, Upcoming Company Events
As portrayed in its financial statements, the presentation of Amneal Pharmaceuticals,'s financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amneal Pharmaceuticals,'s leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Amneal Pharmaceuticals,'s public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Amneal Pharmaceuticals,. Please utilize our Beneish M Score to check the likelihood of Amneal Pharmaceuticals,'s management manipulating its earnings.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 3rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Amneal Pharmaceuticals,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.